Результаты поиска - Jee‐Fu Huang

Отмена результатов
  1. 1
    Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection

    Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection по Chia‐Yen Dai, Ching‐Yeh Lin, Pei‐Chien Tsai, Ping‐Yi Lin, Ming‐Lun Yeh, Chung‐Feng Huang, Wen‐Tsan Chang, Jee‐Fu Huang, Ming‐Lung Yu, Yao‐Li Chen

    Опубликовано 2017
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    Efficacy of TAS-120, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in cholangiocarcinoma patients with FGFR pathway alterations who were previously treated with chemotherapy and other FGFR inhibitors

    Efficacy of TAS-120, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in cholangiocarcinoma patients with FGFR pathway alterations who were previously treated wi... по Funda Meric‐Bernstam, Hendrik-Tobias Arkenau, Ben Tran, Ratislav Bahleda, Robin Kate Kelley, Cinta Hierro, Daniel H. Ahn, Andrew X. Zhu, Milind Javle, Robert Winkler, Huan He, Jee‐Fu Huang, Lipika Goyal

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1386‐patient study from Taiwan

    Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1386‐patient study from Taiwan по Jee‐Fu Huang, Ming‐Lung Yu, C. Lee, Chia‐Yen Dai, Nan Hou, M.-Y. Hsieh, John Wang, Sheng‐Nan Lu, I‐Shyan Sheen, Shi‐Ming Lin, Wan‐Long Chuang, Yun‐Fan Liaw

    Опубликовано 2007
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy

    Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy по Chih‐Wen Lin, Yaw-Sen Chen, Chih-Che Lin, Yun‐Ju Chen, Gin‐Ho Lo, Po‐Huang Lee, Po-Lin Kuo, Chia-Yen Dai, Jee‐Fu Huang, Wang-Long Chung, Ming‐Lung Yu

    Опубликовано 2015
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies

    The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies по Jee‐Fu Huang, M.-Y. Hsieh, Chia‐Yen Dai, Nan Hou, L.-P. Lee, Z.-Y. Lin, Sharon Chen, Liping Wang, M.-Y. Hsieh, Wen‐Yu Chang, Ming‐Lung Yu, Wan‐Long Chuang

    Опубликовано 2007
    Полный текст
    Carta
    Добавить в Избранное
    Сохранить в:
  6. 6
    Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma

    Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma по Yu‐Han Huang, Chi Kuen Chan, Hye Won Lee, Claire Huang, Yen‐Ju Chen, Po-Chun Liu, Sheng‐Nan Lu, Wan‐Long Chuang, Jee‐Fu Huang, Ming‐Lung Yu, Jill Koshiol, Mei‐Hsuan Lee

    Опубликовано 2022
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

    A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C по Ming‐Lung Yu, CY Dai, Jee‐Fu Huang, Nan Hou, L.-P. Lee, Meng‐Hsuan Hsieh, C.-F. Chiu, Lin Zhong, Szu‐Chia Chen, Meng‐Hsuan Hsieh, Liping Wang, Wen‐Yu Chang, Wan‐Long Chuang

    Опубликовано 2006
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment

    Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment по Ming‐Lung Yu, Chung‐Feng Huang, Ming‐Lun Yeh, Pei‐Chien Tsai, Ching‐I Huang, Meng‐Hsuan Hsieh, Ming‐Yen Hsieh, Zu‐Yau Lin, Shinn‐Cherng Chen, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang

    Опубликовано 2016
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis

    Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis по Jee‐Fu Huang, Pei‐Chien Tsai, Ming‐Lun Yeh, Chung‐Feng Huang, Ching‐I Huang, Meng‐Hsuan Hsieh, Chia‐Yen Dai, Jeng‐Fu Yang, Shinn‐Chern Chen, Ming‐Lung Yu, Wan‐Long Chuang, Wen‐Yu Chang

    Опубликовано 2019
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    Efficacy and Safety of Pegylated Interferon Combined with Ribavirin for the Treatment of Older Patients with Chronic Hepatitis C

    Efficacy and Safety of Pegylated Interferon Combined with Ribavirin for the Treatment of Older Patients with Chronic Hepatitis C по Chung‐Feng Huang, Jeng‐Fu Yang, Chia‐Yen Dai, Jee‐Fu Huang, Nai‐Jen Hou, Ming‐Yen Hsieh, Zu‐Yau Lin, Shinn‐Cherng Chen, Ming‐Yuh Hsieh, Liang‐Yen Wang, Wen‐Yu Chang, Wan‐Long Chuang, Ming‐Lung Yu

    Опубликовано 2010
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  11. 11
    Hepatitis C Virus Infection among Injection Drug Users with and without Human Immunodeficiency Virus Co-Infection

    Hepatitis C Virus Infection among Injection Drug Users with and without Human Immunodeficiency Virus Co-Infection по Meng‐Hsuan Hsieh, Jih‐Jin Tsai, Ming‐Yen Hsieh, Chung‐Feng Huang, Ming‐Lun Yeh, Jeng‐Fu Yang, Ko Chang, Wei‐Ru Lin, Chun‐Yu Lin, Tun‐Chieh Chen, Jee‐Fu Huang, Chia‐Yen Dai, Ming‐Lung Yu, Wan‐Long Chuang

    Опубликовано 2014
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  12. 12
    Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial

    Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial по Ming‐Lung Yu, Chia‐Yen Dai, Jee‐Fu Huang, Chang‐Fu Chiu, Yi‐Hsin Yang, Nai‐Jen Hou, Li‐Po Lee, Ming‐Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Ming‐Yuh Hsieh, Liang‐Yen Wang, Wen‐Yu Chang, Wan‐Long Chuang

    Опубликовано 2008
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  13. 13
    Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

    Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients по Ming‐Lung Yu, Chung‐Feng Huang, Jee‐Fu Huang, Ning‐Chia Chang, Jeng‐Fu Yang, Zu‐Yau Lin, Shinn‐Cherng Chen, Ming‐Yuh Hsieh, Liang‐Yen Wang, Wen‐Yu Chang, Yining Li, Mei-Shin Wu, Chia‐Yen Dai, Suh‐Hang Hank Juo, Wan‐Long Chuang

    Опубликовано 2010
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    Scaling up the in-hospital hepatitis C virus care cascade in Taiwan

    Scaling up the in-hospital hepatitis C virus care cascade in Taiwan по Chung‐Feng Huang, Pey‐Fang Wu, Ming‐Lun Yeh, Ching-I Huang, Po‐Cheng Liang, Cheng‐Ting Hsu, Po‐Yao Hsu, Hung‐Yin Liu, Ying‐Chou Huang, Zu‐Yau Lin, Shinn‐Cherng Chen, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu

    Опубликовано 2020
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients

    Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients по Takanori Ito, Vy H. Nguyen, Taku Tanaka, Huiyul Park, Ming‐Lun Yeh, Miwa Kawanaka, Taeang Arai, Masanori Atsukawa, Eileen L. Yoon, Pei‐Chien Tsai, Hidenori Toyoda, Jee‐Fu Huang, Linda Henry, Dae Won Jun, Ming‐Lung Yu, Masatoshi Ishigami, Mindie H. Nguyen, Ramsey Cheung

    Опубликовано 2022
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection

    Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection по Ming‐Lun Yeh, Chung‐Feng Huang, Ching‐I Huang, Jacinta A. Holmes, Meng‐Hsuan Hsieh, Yi‐Shan Tsai, Po‐Cheng Liang, Pei‐Chien Tsai, Ming‐Yen Hsieh, Zu‐Yau Lin, Shinn‐Cherng Chen, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Raymond T. Chung, Ming‐Lung Yu

    Опубликовано 2020
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    Viral Hepatitis Infections in Southern Taiwan: A Multicenter Community‐based Study

    Viral Hepatitis Infections in Southern Taiwan: A Multicenter Community‐based Study по Jeng‐Fu Yang, Chia‐I Lin, Jee‐Fu Huang, Chia‐Yen Dai, Wen‐Yi Lin, Chi‐Kung Ho, Ming‐Yen Hsieh, Li‐Po Lee, Nai‐Jen Ho, Zu‐Yau Lin, Shinn‐Cherng Chen, Ming‐Yuh Hsieh, Liang‐Yen Wang, Ming‐Lung Yu, Wan‐Long Chuang, Wen‐Yu Chang

    Опубликовано 2010
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  18. 18
    Huge Gap Between Clinical Efficacy and Community Effectiveness in the Treatment of Chronic Hepatitis C

    Huge Gap Between Clinical Efficacy and Community Effectiveness in the Treatment of Chronic Hepatitis C по Ming‐Lung Yu, Ming‐Lun Yeh, Pei‐Chien Tsai, Ching‐I Huang, Jee‐Fu Huang, Chung‐Feng Huang, Meng‐Hsuan Hsieh, Po‐Cheng Liang, Yi‐Hung Lin, Ming‐Yen Hsieh, Wen‐Yi Lin, Nai‐Jen Hou, Zu‐Yau Lin, Shinn‐Cherng Chen, Chia‐Yen Dai, Wan‐Long Chuang, Wen‐Yu Chang

    Опубликовано 2015
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes

    Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes по Yi‐Ting Chen, Tzu-I Chen, Tsai-Hsuan Yang, Szu‐Ching Yin, Sheng‐Nan Lu, Xia-Rong Liu, Yun-Zheng Gao, Chih-Jo Lin, Chia-Wei Huang, Jee‐Fu Huang, Ming-Lun Yeh, Chung‐Feng Huang, Chia‐Yen Dai, Wan‐Long Chuang, Hwai‐I Yang, Ming‐Lung Yu, Mei–Hsuan Lee

    Опубликовано 2024
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  20. 20
    Modelling NAFLD disease burden in four Asian regions—2019‐2030

    Modelling NAFLD disease burden in four Asian regions—2019‐2030 по Chris Estes, Henry Lik‐Yuen Chan, Rong‐Nan Chien, Wan‐Long Chuang, James Fung, George Boon‐Bee Goh, Tsung H. Hu, Jee‐Fu Huang, Byoung Kuk Jang, Dae Won Jun, Jia‐Horng Kao, Jin‐Woo Lee, Han‐Chieh Lin, Kathryn Razavi‐Shearer, Wai‐Kay Seto, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Homie Razavi

    Опубликовано 2020
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: